Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
20,609 total articles
Poland's equities finished lower on the session, with the WIG30 ending down 1.07% as stocks in Construction, Basic Materials and Banking weighed on the market. Market breadth favored losers, and commodity moves included sharp gains in crude and Brent oil while June gold futures fell. The zloty was mixed against major currencies and the U.S. dollar …
Turkey's main equity gauge, the BIST 100, finished the trading day lower, weighed by declines in Sports, Banking and Telecoms names. Market breadth favored losers over winners, while energy, precious metals and currency markets posted notable moves during the session. Several individual stocks posted strong gains or sharp losses, and one issuer hit…
Denmark's equity benchmark finished lower on Monday, with losses concentrated in the Chemicals, Personal & Household Goods and Healthcare sectors. The OMX Copenhagen 20 declined 0.86% at the close, while market breadth favored decliners. Energy-related commodity benchmarks advanced, and modest currency moves were recorded in USD/DKK and EUR/DKK…
White House National Economic Council Director Kevin Hassett indicated that a formal currency-swap arrangement for the United Arab Emirates is probably unnecessary, even after UAE officials raised the option during meetings with U.S. financial authorities in Washington. UAE Central Bank Governor Khaled Mohamed Balama discussed the potential of a sw…
Morocco's equity market closed lower on Monday, with the Moroccan All Shares index down 1.03% as declines in Utilities, Banking and Mining weighed on the market. Losers outnumbered winners by a wide margin, while crude and Brent oil rose sharply and gold futures retreated. Currency pairs EUR/MAD and USD/MAD ticked higher and the US Dollar Index Fut…
USA Rare Earth has agreed to buy Brazilian miner Serra Verde for $2.8 billion in cash and shares, adding a heavy-rare-earth asset to its growing mining, processing and magnet-making operations. The transaction, slated to close in the third quarter of 2026, follows earlier U.S. government-linked financing packages for both companies and includes a 1…
Barclays upgraded Okta from equal weight to overweight and raised its price target to $90 from $85, pointing to identity security rising to the top of CIO spending priorities and an emerging agentic security opportunity. The bank raised its fiscal 2028 free cash flow estimate to $991 million and highlighted improving survey and intra-quarter data a…
Norway's benchmark Oslo OBX finished higher on Monday, driven by advances in the Healthcare Equipment & Services, Pharma Biotech & Life Sciences and Utilities sectors. The index gained 0.56% at the close. Notable movers included a strong jump in TGS NOPEC Geophysical Company ASA, mid-single-digit gains for Var Energi ASA and Aker BP ASA, while Norw…
Israel's benchmark TA-35 index closed up 0.53% on Monday, paced by advances in Technology, Biomed and Communication names. Renewable energy and select pharmaceuticals were among the session's top performers, while several insurance and financial stocks lagged. Commodity markets saw sharp moves, with crude and Brent oil jumping and June gold futures…
Greece's benchmark index closed sharply lower on Monday, with the Athens General Composite losing 2.14% as declines in the Banking, Telecoms and Household sectors pulled the market down. While a handful of companies including Interlife General Insurance, Athens Medical and Thessaloniki Port Authority posted gains, larger drops among energy, metals …
AEVEX Corp. (NYSE: AEVX) rallied sharply Monday, rising 30% to $35.80 as the stock extended gains following last week’s initial public offering. The company, backed by Madison Dearborn Partners, priced 16 million shares at $20 each and raised $320 million in the U.S. offering. Regulatory filings show substantial revenue exposure to Ukraine and prog…
Rocket Lab USA's stock climbed 5% on Monday after favorable analyst commentary and upgraded price targets. Stifel raised its target to $105 while maintaining a Buy rating, matching the Street High, and Cantor Fitzgerald reiterated an Overweight rating with an $85 target. Management's comments at the Space Symposium and recent product and acquisitio…
Arcus Biosciences said an Independent Data Monitoring Committee recommended stopping the Phase 3 STAR-121 study in first-line metastatic non-small cell lung cancer for futility, prompting a roughly 4% decline in the company’s stock. The decision affects the domvanalimab-plus-zimberelimab combination versus pembrolizumab plus chemotherapy, and prece…
Nektar Therapeutics' stock climbed 20% following the release of 52-week results from its Phase 2b REZOLVE-AA trial of rezpegaldesleukin in patients with severe-to-very-severe alopecia areata. The extension-phase data show a higher proportion of patients achieving predefined scalp-hair coverage thresholds versus placebo, and the company said the saf…
Members of the family that controls Brown-Forman Corp., the maker of Jack Daniel's, are reported to prefer a potential sale to French distiller Pernod Ricard SA rather than an offer from U.S. competitor Sazerac Co. Discussions under consideration would tilt heavily toward stock consideration, and would be structured to increase the family's ownersh…
Stocks across market-cap segments recorded sharp moves on Monday as deal headlines, analyst upgrades and corporate disclosures influenced share prices. Topbuild surged after a $17 billion acquisition announcement, Kaspi.kz climbed, and a mix of technology, biotech and special-purpose acquisition companies logged both meaningful gains and declines. …
Evercore ISI analyst Amit Daryanani added Arista Networks and IBM to the firm's tactical outperform list as both companies approach first-quarter earnings. Evercore cites beat-and-raise setups: for IBM, a potential revenue and EPS upside tied in part to the earlier-than-expected close of the Confluent acquisition; for Arista, stronger AI demand, ga…
Wolfe Research’s valuation study finds that major managed care companies are projected to earn well below their target margins in 2026, with shortfalls ranging from roughly one-third to four times the targets. Molina, Humana, and Centene show the largest gaps, while CVS Health, Elevance Health, and UnitedHealth Group also report substantial underpe…
Renewed tensions between Washington and Tehran over the weekend have complicated hopes for a permanent ceasefire, analysts at Wolfe Research say. U.S. actions, including the seizure of an Iranian-flagged vessel, and mixed signals from Iranian authorities have left the Strait of Hormuz effectively closed to commercial traffic. With a two-week pause …
Agnico Eagle Mines said it will acquire Rupert Resources and Aurion Resources and purchase B2Gold's 70% stake in the Fingold joint venture, moves that give the company full control of a contiguous land package in Finland's Central Lapland Greenstone Belt. The combination integrates the Ikkari gold project with Agnico's existing Kittila mine and con…
On April 20, Adobe announced CX Enterprise, a collection of AI-driven tools aimed at automating and personalizing digital marketing for corporate clients. The launch comes as software stocks face selling pressure amid investor concern about autonomous AI offerings from startups such as Anthropic and OpenAI. Adobe reported a 2.2% rise in morning tra…
RBC Capital Markets downgraded GitLab to sector perform from outperform and trimmed its price target to $25 from $33, highlighting a series of near-term challenges that are expected to constrain upside. While the firm remains constructive on GitLab's longer-term position as a DevSecOps platform, it flagged several revenue and sales risks, and said …
Agios Pharmaceuticals stock dropped 25% after Novo Nordisk announced positive trial results for its experimental sickle cell therapy etavopivat. Novo reported a 27% reduction in vaso-occlusive crisis events and roughly a four-month delay to the first such event versus standard of care. Agios is pursuing an accelerated approval path with the FDA for…
Equity markets have seen pronounced moves in recent months, with large trading profits for investment banks amid Middle East-related volatility and a particularly strong performance in April for stocks identified by an AI-driven InvestingPro strategy. The service is offering a limited-time sale of up to 55% off, while multiple AI picks have produce…
The Federal Reserve’s vice chair for supervision, Michelle Bowman, has indicated to senior bank executives that regulators do not anticipate a repeat of last year’s intensive industry campaign to resist tougher capital requirements. Fed officials have circulated softened drafts of the "Basel III" and "GSIB surcharge" rules that the central bank say…
